Skip to main content
Nykode Therapeutics ASA logo

Nykode Therapeutics ASA — Investor Relations & Filings

Ticker · NYKD ISIN · NO0010714785 LEI · 254900UKQHWYZJD22017 OL Manufacturing
Open in API
Filings indexed 493 across all filing types
Latest filing 2022-02-22 Director's Dealing
Country NO Norway
Listing OL NYKD

About Nykode Therapeutics ASA

https://nykode.com/

Nykode Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery and development of novel immunotherapies. The company's core is its proprietary Vaccibody™ technology, a modular platform designed to create targeted vaccines. This technology works by linking antigens to a targeting unit, which delivers them directly to antigen-presenting cells. This mechanism is engineered to induce rapid, potent, and long-lasting T-cell and antibody immune responses. Nykode's development pipeline is focused on generating therapeutics for a range of diseases, with a primary emphasis on oncology and infectious diseases.

Recent filings

Filing Released Lang Actions
Mandatory notification of acquisition of shares by primary insider
Director's Dealing Classification · 99% confidence The document explicitly states it is a 'Mandatory notification of acquisition of shares by primary insider' and details a transaction by the Chairman of the Board (Martin Nicklasson). This directly corresponds to the definition of Director's Dealing (insider trades). The filing type code for Director's Dealing is DIRS.
2022-02-22 English
Mandatory notification of exercise of warrants
Director's Dealing Classification · 99% confidence The document details a transaction involving a person discharging managerial responsibilities (Christian Åbyholm, Board member) concerning the issuer's financial instruments (Warrants in Nykode Therapeutics AS). Specifically, it reports the 'Exercise of warrants' for a volume of 100,000 units at NOK 18 each, dated 15.02.2022. This structure—reporting personal share transactions by directors/executives—is the defining characteristic of a Director's Dealing report, which corresponds to the code DIRS.
2022-02-15 English
Mandatory notification of exercise of warrants
Share Issue/Capital Change Classification · 99% confidence The document text explicitly states 'Mandatory notification of exercise of warrants' and details a transaction by a board member (Christian Åbyholm) exercising warrants. This type of transaction notification, involving personal share dealings by insiders (directors/executives), directly corresponds to the definition of Director's Dealing (DIRS). Although it mentions an 'attached document', the core subject matter is the insider transaction itself, making DIRS a more specific fit than the general RPA or RNS fallback.
2022-02-15 English
Nykode Therapeutics to Present at SVB Leerink 2022 Global Healthcare Conference
Report Publication Announcement Classification · 99% confidence The document is a short announcement titled "Company Announcement" stating that Nykode Therapeutics will present at the SVB Leerink 2022 Global Healthcare Conference and that an updated corporate presentation will be available on their website. The document length is very short (3479 characters) and it explicitly mentions that a presentation will be available and provides a link to access the webcast/presentation. This fits the definition of a Report Publication Announcement (RPA) because it announces the availability of presentation materials rather than being the presentation itself or a comprehensive financial report (like 10-K or IR).
2022-02-14 English
Nykode Therapeutics to Present at SVB Leerink 2022 Global Healthcare Conference
Report Publication Announcement Classification · 99% confidence The document is a short press release announcing that Nykode Therapeutics executives will present at the SVB Leerink 2022 Global Healthcare Conference on February 18, 2022. It explicitly states that an updated corporate presentation will be available on their website at a specific time and provides links to access the live/archived webcast of the presentation. Since the document itself is an announcement about an upcoming presentation and the availability of presentation materials, rather than the presentation itself (IP) or a comprehensive financial report (IR/10-K), it fits best under the category for announcing the publication of reports or presentations. Given the context of an investor event and presentation availability, 'Report Publication Announcement' (RPA) is the most appropriate classification, as it announces the release of investor materials (the presentation webcast). It is too short and focused on the announcement itself to be classified as an Investor Presentation (IP).
2022-02-14 English
Nykode Therapeutics announces completion of patient enrollment in its Phase 2 trial of VB10.16 in combination with atezolizumab for the treatment of advanced cervical cancer
Regulatory Filings Classification · 95% confidence The document is a formal announcement from Nykode Therapeutics regarding a clinical trial milestone (completion of patient enrollment in a Phase 2 trial for VB10.16). It details the trial status, expected data release timeline, and provides general company information. This type of announcement, focusing on operational and clinical progress rather than comprehensive financial results (10-K, IR) or management changes (MANG), is best classified as a general Regulatory Filing or an announcement related to ongoing operations. Since there is no specific category for 'Clinical Trial Update' and it is not a formal financial report, an Earnings Release (ER), or a Call Transcript (CT), the most appropriate general category for a significant operational update that is not a standard financial filing is Regulatory Filings (RNS), which serves as a broad category for non-standard regulatory disclosures. However, given the context of financial reporting databases, announcements detailing clinical progress, especially those that might impact investor perception, often fall under general news releases. Since RNS is the fallback for miscellaneous filings, and this is a specific operational update, RNS is the best fit among the provided options.
2022-02-11 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.